Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, July 2, 2014, 88 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $147.42 to $14,640,500.00. Highlighted Stocks Traded by Insiders: Accenture (ACN) - FREE Research Report Deblaere Johan, who is Chief Operating Officer at Accenture, sold 1,600 shares at $81.29 on July 2, 2014. Following this transaction, the Chief Operating Officer owned 179,141 shares meaning that the stake was reduced by 0.89% with the 1,600-share transaction. Shook Ellyn, who is Chief Human Resources Officer at Accenture, sold 3,100 shares at $80.79 on July 2, 2014. Following this transaction, the Chief Human Resources Officer owned 57,343 shares meaning that the stake was reduced by 5.13% with the 3,100-share transaction. The shares most recently traded at $81.32, up $0.53, or 0.65% since the insider transaction. Historical insider transactions for Accenture go as follows:
4-Week # shares sold: 33,333
12-Week # shares sold: 33,333
24-Week # shares sold: 38,469
The average volume for Accenture has been 2.7 million shares per day over the past 30 days. Accenture has a market cap of $51.3 billion and is part of the technology sector and computer software & services industry. Shares are down 1.41% year-to-date as of the close of trading on Wednesday. Accenture plc provides management consulting, technology, and business process outsourcing (BPO) services worldwide. The company operates through Communications, Media & Technology; Financial Services; Health & Public Service; Products; and Resources segments. The stock currently has a dividend yield of 2.29%. The company has a P/E ratio of 18.3. Currently, there are 8 analysts who rate Accenture a buy, no analysts rate it a sell, and 9 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on ACN - FREETheStreet Quant Ratings rates Accenture as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, growth in earnings per share and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Accenture Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.